Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients.

Nasri, H. (2012) Association of Ca×PO4 product with levels of serum C-reactive protein in regular hemodialysis patients. Journal of renal injury prevention, 1 (2). pp. 55-9. ISSN 2345-2781

[img]
Preview
Text
16.pdf

Download (422kB) | Preview

Abstract

INTRODUCTION Numerous studies have attempted to identify risk factors for mortality and morbidity in maintenance hemodialysis patients. In this study we sought to examine the association of the levels of serum C-reactive protein (CRP) with value of Ca×PO4 product, in stable hemodialysis patients. PATIENTS AND METHODS Based on the severity of secondary hyperparathyroidism, patients being treated with oral active vitamin D3, calcium carbonate/Renagel tablets at various doses. Fasting serum 25-hydroxy vitamin D and intact serum parathormone and also serum blood urea nitrogen, CRP, calcium, phosphorus, alkaline phosphatase was measured. RESULTS A total of 41 patients, enrolled to the study. The mean patients' age were 46(17.6) years. The value of serum CRP of patients was 8.6 (6.6) mg/l (median 6 mg/l). The value of Ca×PO4 product was 50.5(15.5) mg2/dl2 (median: 50 mg(2)/dl(2)). In this study, a significant inverse association between Ca×PO4 product and the age of the patients was seen. A significant positive correlation of logarithm of serum CRP with Ca×PO4 product was found. CONCLUSION The result of this study, revealed the need to further attention to hyperphosphatemia in hemodialysis patients.

Item Type: Article
Uncontrolled Keywords: Hyperphosphatemia End-stage renal disease Hemodialysis
Subjects: WJ Urogenital System
QU Biochemistry
Divisions: Faculty of Medicine > Department of Clinical Sciences > Department of Urology
Depositing User: zahra bagheri .
Date Deposited: 15 Aug 2017 04:57
Last Modified: 15 Aug 2017 04:57
URI: http://eprints.skums.ac.ir/id/eprint/2966

Actions (login required)

View Item View Item